Deal Announcements

AdvanDx Closes $15 Million Third Funding Round

Wednesday, September 19, 2007 5:00:00 AM PDT | VentureDeal Staff

WOBURN, MA -- Medical test device maker AdvanDx, Inc. announced the close of its series C round, securing $15 million in new venture capital and strategic investment.

AdvanDx develops and markets molecular-based, in-vitro diagnostic tests that help clinicians and researchers diagnose and prevent infectious diseases.

France-based bioMerieux invested in the round, along with SLS Ventures and LD Pensions.  AdvanDx recently announced an exclusive distribution partnership with bioMerieux.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1